179 related articles for article (PubMed ID: 25102962)
1. Mycobacterial diseases developed during anti-tumour necrosis factor-α therapy.
Yoo JW; Jo KW; Kang BH; Kim MY; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
Eur Respir J; 2014 Nov; 44(5):1289-95. PubMed ID: 25102962
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of mycobacterial infections associated with anti-rheumatic medications.
Brode SK; Jamieson FB; Ng R; Campitelli MA; Kwong JC; Paterson JM; Li P; Marchand-Austin A; Bombardier C; Marras TK
Thorax; 2015 Jul; 70(7):677-82. PubMed ID: 25911222
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterial infections in patients treated with tumor necrosis factor antagonists in South Korea.
Lee SK; Kim SY; Kim EY; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Kang YA
Lung; 2013 Oct; 191(5):565-71. PubMed ID: 23728990
[TBL] [Abstract][Full Text] [Related]
4. [Biologics and mycobacterial diseases].
Tsuyuguchi K; Matsumoto T
Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
[TBL] [Abstract][Full Text] [Related]
5. Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis.
Jo KW; Hong Y; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee SD; Kim WS; Kim DS; Shim TS
Respir Med; 2013 Nov; 107(11):1797-802. PubMed ID: 24029000
[TBL] [Abstract][Full Text] [Related]
6. Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients.
Yoo JW; Jo KW; Kim SH; Lee SO; Kim JJ; Park SK; Lee JH; Han DJ; Hwang S; Lee S; Shim TS
Transpl Int; 2016 May; 29(5):549-58. PubMed ID: 26840221
[TBL] [Abstract][Full Text] [Related]
7. The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy.
Winthrop KL; Baxter R; Liu L; McFarland B; Austin D; Varley C; Radcliffe L; Suhler E; Choi D; Herrinton LJ
Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):229-35. PubMed ID: 21351303
[TBL] [Abstract][Full Text] [Related]
8. Risk of tuberculosis in patients treated with anti-tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden.
Jung SM; Ju JH; Park MS; Kwok SK; Park KS; Kim HY; Yim HW; Park SH
Int J Rheum Dis; 2015 Mar; 18(3):323-30. PubMed ID: 25557144
[TBL] [Abstract][Full Text] [Related]
9. Clinical investigation of nontuberculous mycobacterial lung disease in Japanese patients with rheumatoid arthritis receiving biologic therapy.
Yamakawa H; Takayanagi N; Ishiguro T; Kanauchi T; Hoshi T; Sugita Y
J Rheumatol; 2013 Dec; 40(12):1994-2000. PubMed ID: 24187100
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterial diseases and antitumour necrosis factor therapy in USA.
Winthrop KL; Baxter R; Liu L; Varley CD; Curtis JR; Baddley JW; McFarland B; Austin D; Radcliffe L; Suhler E; Choi D; Rosenbaum JT; Herrinton LJ
Ann Rheum Dis; 2013 Jan; 72(1):37-42. PubMed ID: 22523429
[TBL] [Abstract][Full Text] [Related]
11. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
12. Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada.
Brode SK; Jamieson FB; Ng R; Campitelli MA; Kwong JC; Paterson JM; Li P; Marchand-Austin A; Bombardier C; Marras TK
Chest; 2014 Sep; 146(3):563-572. PubMed ID: 24384637
[TBL] [Abstract][Full Text] [Related]
13. Nontuberculous mycobacterial infection in rheumatoid arthritis patients: a single-center experience in South Korea.
Lim DH; Kim YG; Shim TS; Jo KW; Ghang B; Ahn SM; Hong S; Lee CK; Yoo B
Korean J Intern Med; 2017 Nov; 32(6):1090-1097. PubMed ID: 28063416
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the tuberculosis risk in patients receiving anti-tumor necrosis factor-α treatment.
Borekci S; Atahan E; Demir Yilmaz D; Mazıcan N; Duman B; Ozguler Y; Musellim B; Hamuryudan V; Ongen G
Respiration; 2015; 90(3):191-8. PubMed ID: 26137891
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis and Nontuberculous Mycobacterial Infections in Patients with Spondyloarthritis: A Population-Based Study.
Yang J; Jang HA; Cho H; Im YH; Kim JH
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674225
[No Abstract] [Full Text] [Related]
16. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
Hamdi H; Mariette X; Godot V; Weldingh K; Hamid AM; Prejean MV; Baron G; Lemann M; Puechal X; Breban M; Berenbaum F; Delchier JC; Flipo RM; Dautzenberg B; Salmon D; Humbert M; Emilie D;
Arthritis Res Ther; 2006; 8(4):R114. PubMed ID: 16859506
[TBL] [Abstract][Full Text] [Related]
17. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
[TBL] [Abstract][Full Text] [Related]
18. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.
Seong SS; Choi CB; Woo JH; Bae KW; Joung CL; Uhm WS; Kim TH; Jun JB; Yoo DH; Lee JT; Bae SC
J Rheumatol; 2007 Apr; 34(4):706-11. PubMed ID: 17309133
[TBL] [Abstract][Full Text] [Related]
19. [The epidemiology of nontuberculous mycobacterial diseases in Hiroshima Prefecture].
Shigeto E; Sato H; Kawahara S; Kuraoka T; Miyazawa T
Kekkaku; 1996 Sep; 71(9):513-8. PubMed ID: 8914386
[TBL] [Abstract][Full Text] [Related]
20. Hospitalizations of patients treated with anti-tumor necrosis factor-α agents -- a retrospective cohort analysis.
Zisman D; Haddad A; Hashoul S; Laor A; Bitterman H; Rosner I; Eder L; Balbir-Gurman A; Mader R; Milman U
J Rheumatol; 2013 Jan; 40(1):16-22. PubMed ID: 23070992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
